Hospital Guide: Zhejiang University Second Affiliated Hospital

Founded in 1869 as Zhejiang's birthplace of Western medicine, we are China's first Class III Grade A hospital and a global benchmark for integrated clinical-research-transformation excellence.

I. Hospital Overview & Global Positioning

Legacy & Scale: 156-year history; core medical support unit for the G20 Summit and the Hangzhou Asian Games.

Multi-campus system: Binjiang Campus is an advanced tertiary care hub.

Xiaoshan Headquarters (opening 2025): China's largest new hospital project (2,500 beds, 107 ORs), designed as a "world-class medical-scientific complex".

Accolades: Top 10 in China's public hospital performance evaluations (6 consecutive years); designated National Medical Center for cardiovascular and critical care innovation.

II. Cutting-Edge Medical Capabilities

Smart imaging & intervention: CBCT-guided tumor embolization achieves sub-lobar precision for liver cancer (e.g. millimeter-level vessel targeting). AI coronary analysis enables non-invasive FFR calculation replacing pressure wires, reducing costs by 40%. Real-time 3D ultrasound + intraoperative neurophysiological monitoring for complex valve surgeries.

Robotics & hybrid ORs: Da Vinci Xi Surgical System, hybrid angio-suites and the M6 CyberKnife.

Cardiovascular Center: transcatheter valve innovations — developed China's first retrievable aortic valve and the DragonFly mitral valve repair system. Pioneered the "Hangzhou Protocol" for high-risk bicuspid valve cases — adopted in 18 centers across 12 countries (Italy, Turkey, Argentina, etc.). Landmark case (July 2025): guided Turkey's top hospital in implanting Chinese-made valves in a 91-year-old with extreme aortic stenosis.

Precision oncology & interventional therapy: CBCT-guided TACE reduced radiation exposure by 30% and contrast-induced kidney injury risk. Multidisciplinary teams for liver, lung and neuroendocrine tumors.

Neurovascular & orthopedic-robotic centers: the Xiaoshan HQ will feature dedicated Brain & Heart Centers with AI-operative integration.

III. World-Renowned Expert Teams

Prof. Wang Jian'an: Academician of the Chinese Academy of Sciences; Director of the National Key Lab for Transvascular Implants; global ambassador for "China-made valve solutions"; trained surgeons in 12 countries.

Prof. Jiang Jun: cardiovascular AI pioneer; developed non-invasive FFR technology.

Prof. Li Qiang: leader in CBCT-guided tumor interventions.

Multidisciplinary alliances: 70% of senior physicians trained at Mayo Clinic, Cleveland Clinic or European centers.

IV. Hangzhou: Asia's Rising Med-Travel Destination

Visa facilitation: 240-hour visa-free transit; medical fast-track visas proposed by Academician Wang Jian'an.

Cross-border medical access: early adoption of overseas-approved drugs/devices (e.g. FARAPULSE PFA).

Cultural attractions: West Lake UNESCO Site (20-min drive from Binjiang Campus); Lingyin Temple & Grand Canal heritage tours.

V. International Patient Services & Logistics

One-stop coordination: multilingual case managers (English/Japanese/Arabic).

Financial & cultural support: direct billing with AXA/Allianz; Halal/Kosher meals; prayer rooms.

Binjiang Campus: 1828 Binsheng Rd, Binjiang District. From Xiaoshan Airport: Metro Line 7 → Line 6 (45 mins); taxi (30 km, ¥100).

Xiaoshan HQ (opens Q4 2025): Shushan Rd & South Fourth Rd, Xiaoshan District. From Hongqiao (Shanghai): high-speed rail to Hangzhou East (1 hr) → Metro Line 2 (50 mins).